Molnupiravir for COVID-19 (ID6340).: a single technology appraisal

Ribeiro, Ines, Woods, Lois, Kalita, Neelam, Scott, David Alexander and Frampton, Geoff (2024) Molnupiravir for COVID-19 (ID6340).: a single technology appraisal National Institute for Health Research 188pp.

Record type: Monograph (Project Report)

Abstract

This report is a critique of the company’s submission (CS) to NICE from Merck Sharp & Dohme on the clinical effectiveness and cost effectiveness of molnupiravir for treating COVID-19. It identifies the strengths and weaknesses of the CS. Clinical experts were consulted to advise the external assessment group (EAG) and to help inform this report.

Text

Molnupiravir NICE ERG Report - Version of Record

Available under License Creative Commons Attribution.

Download (3MB)

More information

Published date: 5 September 2024

Identifiers

Local EPrints ID: 504151

URI: http://eprints.soton.ac.uk/id/eprint/504151

PURE UUID: 516abd9c-2207-4597-844d-94f5afee56dc

ORCID for Ines Ribeiro:

orcid.org/0000-0001-8464-4513

ORCID for Lois Woods:

orcid.org/0000-0002-4587-9149

ORCID for Neelam Kalita:

orcid.org/0000-0002-0973-0160

ORCID for David Alexander Scott:

orcid.org/0000-0001-6475-8046

ORCID for Geoff Frampton:

orcid.org/0000-0003-2005-0497

Catalogue record

Date deposited: 28 Aug 2025 16:30

Last modified: 29 Aug 2025 02:04

Export record

Share this record

Share this on Facebook Share this on Twitter Share this on Weibo

Contributors

Author: Ines Ribeiro

Author: Lois Woods

Author: Neelam Kalita

Author: David Alexander Scott

Author: Geoff Frampton

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information